Summary:
PlatinumRx’s successful funding round not only signifies a milestone for the startup but also heralds a new era of affordability and convenience in medication procurement, promising transformative benefits for patients across the nation.
In a significant stride for the healthcare sector, Bangalore-based online pharmacy startup PlatinumRx has successfully raised $800,000 in seed funding. Led by India Quotient and backed by angel investors, this funding catapults PlatinumRx into the forefront of innovation, aiming to redefine accessibility in medication procurement.
PlatinumRx Secures $800,000 in Seed Funding to Revolutionize Medication Access
The infusion of funds marks a pivotal moment for PlatinumRx as it gears up to expand its operations, strengthen its warehousing and distribution network, and broaden its reach across the nation. With a vision to transform chronic patient care, PlatinumRx plans to utilize a portion of the raised capital to diversify its product offerings and extend its geographical footprint.
Founded by Ashutosh Pandey and Piyush Kumar, PlatinumRx sets itself apart by offering a unique substitution engine, empowering consumers to discover equivalent substitute medicines with the same potency, efficacy, and affordability. By curating a selection of best-value substitutes from renowned brands like Cipla, Abbott, and Alkem, PlatinumRx aims to alleviate the financial burden associated with long-term medication needs.
Ashutosh Pandey and Piyush Kumar, Co-founders of PlatinumRx, expressed their excitement for partnering with India Quotient, citing the firm’s alignment with their vision to democratize medication procurement for all Indians.
Gagan Goyal of India Quotient emphasized the urgent need for cost-effective solutions amidst rising chronic health conditions. He stressed the importance of scaling awareness to cater to a vast Total Addressable Market (TAM) and ease the financial strain on individuals managing chronic illnesses.
Also read: Tesla Partners with Tata Electronics for Semiconductor Supply, Eyes Expansion in India
With the raised capital, PlatinumRx aims to extend its outreach to a wider demographic of patients seeking affordable yet high-quality medications. Presently, the startup boasts coverage of over 20,000 pin codes, with swift delivery services within two to three days and same-day delivery available in Bengaluru. Additionally, PlatinumRx has forged partnerships with several old age homes and rehabilitation centers in Bengaluru, demonstrating its commitment to reducing medical expenses for vulnerable populations.
Reports indicate a promising outlook for the online pharmacy market in India, with projections estimating revenue generation of $453.30 million in 2024. The sector is poised for steady growth, anticipated to reach approximately $649.50 million by 2028, underscoring the immense potential for innovation and accessibility in healthcare services.
PlatinumRx’s successful funding round not only signifies a milestone for the startup but also heralds a new era of affordability and convenience in medication procurement, promising transformative benefits for patients across the nation.
